Publication Information

{'id': 'https://openalex.org/W2388977500', 'doi': None, 'title': 'Analysis of adverse drug raction:on 262 cases report', 'display_name': 'Analysis of adverse drug raction:on 262 cases report', 'publication_year': 2011, 'publication_date': '2011-01-01', 'ids': {'openalex': 'https://openalex.org/W2388977500', 'mag': '2388977500'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-PLHY201103004.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764472741', 'display_name': 'Chinese Journal of Clinical Rational Drug Use', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4361730451', 'host_organization_name': 'Hebei Science and Technology Association', 'host_organization_lineage': ['https://openalex.org/P4361730451'], 'host_organization_lineage_names': ['Hebei Science and Technology Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5028651989', 'display_name': 'Zhu Ai-guo', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Zhu Ai-guo', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5028651989'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11117', 'display_name': 'Drug-Induced Adverse Reactions', 'score': 0.8963, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11117', 'display_name': 'Drug-Induced Adverse Reactions', 'score': 0.8963, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11943', 'display_name': 'Pharmacovigilance and Adverse Drug Reactions', 'score': 0.8881, 'subfield': {'id': 'https://openalex.org/subfields/3005', 'display_name': 'Toxicology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13095', 'display_name': 'Plant-based Medicinal Research', 'score': 0.7898, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/adverse-drug-reaction', 'display_name': 'Adverse drug reaction', 'score': 0.51203495}, {'id': 'https://openalex.org/keywords/drug-reaction', 'display_name': 'Drug reaction', 'score': 0.44541222}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9759418}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.6293355}, {'id': 'https://openalex.org/C2780542314', 'wikidata': 'https://www.wikidata.org/wiki/Q45959', 'display_name': 'Adverse drug reaction', 'level': 3, 'score': 0.51203495}, {'id': 'https://openalex.org/C2993432071', 'wikidata': 'https://www.wikidata.org/wiki/Q45959', 'display_name': 'Drug reaction', 'level': 3, 'score': 0.44541222}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.43791953}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.43150067}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.36102766}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-PLHY201103004.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764472741', 'display_name': 'Chinese Journal of Clinical Rational Drug Use', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4361730451', 'host_organization_name': 'Hebei Science and Technology Association', 'host_organization_lineage': ['https://openalex.org/P4361730451'], 'host_organization_lineage_names': ['Hebei Science and Technology Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.76, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2392272311', 'https://openalex.org/W2391950831', 'https://openalex.org/W2390303881', 'https://openalex.org/W2388316772', 'https://openalex.org/W2387912805', 'https://openalex.org/W2383765432', 'https://openalex.org/W2380213773', 'https://openalex.org/W2379467729', 'https://openalex.org/W2379368001', 'https://openalex.org/W2377363160', 'https://openalex.org/W2375013218', 'https://openalex.org/W2373218029', 'https://openalex.org/W2371276315', 'https://openalex.org/W2367618615', 'https://openalex.org/W2360054283', 'https://openalex.org/W2356924463', 'https://openalex.org/W2355364922', 'https://openalex.org/W2355194065', 'https://openalex.org/W2353980077', 'https://openalex.org/W2353812772'], 'abstract_inverted_index': {'Objective': [0], 'To': [1], 'explore': [2], 'the': [3, 14, 30, 64, 132, 140], 'factirs,general': [4], 'rule': [5], 'and': [6, 12, 28, 39, 45, 80, 89, 125, 138], 'characteristics': [7], 'of': [8, 16, 32, 51, 87, 127, 136, 143], 'adverse': [9], 'drug': [10, 26], 'raction(ADR)': [11], 'evaluate': [13], 'quality': [15, 31, 49], 'ADR': [17, 33, 36, 72, 123], 'reports': [18], 'in': [19], 'order': [20], 'to': [21, 115, 121, 130], 'promote': [22], 'clinic': [23], 'rational': [24, 134], 'safe': [25], 'use': [27, 135], 'improve': [29], 'monitoring.Methods': [34], 'Analyzed': [35], "patients'": [37], 'age': [38], 'sex,drug': [40], 'kinds,ADR-involved': [41], 'organs': [42], 'or': [43], 'systems': [44], 'clinical': [46, 133], 'manifestations,ADR': [47], 'report': [48], 'etc': [50], '262': [52], 'cases': [53, 71], 'ADR.Results': [54], 'ADR-involving': [55], 'drugs': [56, 137], 'totaled': [57], '84': [58], 'kinds,of': [59], 'which': [60], 'antiinfective': [61], 'agents': [62], 'occupied': [63], 'first': [65], 'place,followed': [66], 'by': [67, 75, 84], 'Chinese': [68], 'traditional': [69], 'medicines;247(94.27%)': [70], 'were': [73, 81, 92, 96, 101, 108], 'induced': [74], 'intravenous': [76], 'rorte;ADR': [77], 'occurred': [78], 'temically': [79], 'characterized': [82], 'predominantly': [83], 'allergic': [85], 'reactions': [86], 'skin': [88], 'its': [90], 'appendants,there': [91], '179': [93], 'cases(66.54%);234': [94], 'cases(89.31%)': [95], 'common': [97, 104], 'ADR,while': [98, 105], '19': [99], 'cases(7.25%)': [100], 'new': [102, 109], 'but': [103], '9': [106], 'cases(3.44%)': [107], 'severe': [110], 'ADR;ADR': [111], 'reporting': [112], 'quantity': [113], 'remained': [114], 'be': [116], 'enhanced.Conclusion': [117], 'It': [118], 'is': [119], 'necessary': [120], 'strengthen': [122], 'monitoring': [124], 'publicizing': [126], 'ADR-related': [128], 'knowledge': [129], 'guide': [131], 'reduce': [139], 'repetitive': [141], 'currence': [142], 'ADR.': [144]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2388977500', 'counts_by_year': [], 'updated_date': '2024-12-11T20:44:03.936678', 'created_date': '2016-06-24'}